EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A ptsH mutation suppresses growth defects and antibiotic sensitivity in a cpgA mutant defective in metabolite proofreading

Ankita J Sachla iD, Ahmed Gaballa iD, Diana Herrera, John D Helmann iD

Journal of Bacteriology · 2025

DOI: 10.1128/jb.00162-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bacteriology, 2025. Verfasst von Ankita J Sachla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Proteins, Bacillus subtilis, Phosphoenolpyruvate Sugar Phosphotransferase System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacillus subtilis CpgA ( c ircularly p ermuted G TPase) is a ribosome assembly GTPase that has a secondary function as a metabolite proofreading enzyme. CpgA hydrolyzes 4-phosphoerythronate, a toxic metabolite produced from erythrose-4-phosphate by glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In a ∆ cpgA strain, carbon sources that feed into the pentose phosphate pathway trigger metabolic intoxication. This results in poor growth and increased sensitivity to antibiotics that block peptidoglycan synthesis, a process reliant on sugars from central metabolism. Here, we describe a mutation in ptsH ( ptsH -G54D) that improves growth of a ∆ cpgA strain on media containing both glucose and gluconate. The ptsH gene encodes the histidine-containing phosphocarrier protein (HPr) that functions in phosphotransferase system sugar import and gene regulation. Prior studies of HPr suggested three possible mechanisms to account for the ability of HPr-G54D to increase fitness of the ∆ cpgA strain: (i) restricting HPr-dependent uptake of glucose, (ii) reducing the GAPDH-dependent production of 4-phosphoerythronate, or (iii) decreasing expression of genes required for uptake and catabolism of gluconate. Here, we present evidence consistent with the third model: HPr-G54D improves fitness of a ∆ cpgA strain by increasing catabolite repression of the gluconate operon. Consistently, genetic suppression by HPr-G54D requires Ser46, a site of regulatory phosphorylation important for carbon catabolite repression. In addition, we demonstrate that the metabolic proofreading function of CpgA is conserved among related gram-positive bacteria. IMPORTANCE Metabolism relies on the concerted action of hundreds of enzymes, many of which have some activity with non-canonical substrates. The resulting reactions constitute an often-ignored underground metabolism. Glyceraldehyde-3-phosphate dehydrogenase catalyzes a secondary reaction that produces 4-phosphoerythronate, a toxic dead-end metabolite. Bacillus subtilis CpgA is a widely conserved metabolite proofreading enzyme that protects cells against metabolic intoxication, which can increase antibiotic sensitivity. Loss of CpgA can be suppressed by an altered function mutation affecting the histidine-containing phosphocarrier protein (HPr). This mutant HPr protein increases carbon catabolite repression to restrict import of intoxicating gluconate. These studies highlight the ability of mutations in HPr to rewire carbon catabolism to help avoid the toxic effects of metabolic dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacterial ProteinsBacillus subtilisPhosphoenolpyruvate Sugar Phosphotransferase SystemGlucoseMutationGene Expression Regulation, BacterialGluconates

Stichwörter der Autor:innen

CRISPRallosteric regulationcefuroximefosfomycinglyceraldehyde-3-phosphate dehydrogenase (GAPDH)histidine protein (HPr)moenomycinpromiscuous enzymeribosome assembly GTPase

Substanzen

Anti-Bacterial AgentsBacterial ProteinsPhosphoenolpyruvate Sugar Phosphotransferase SystemGlucoseGluconatesphosphocarrier protein HPrgluconic acid

Autor:innen und Institutionen

  • Department of Microbiology, Cornell University, Ithaca, New York, USA.

ORCID-Profile: Ankita J Sachla, Ahmed Gaballa, John D Helmann

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Sachla, A. J., Gaballa, A., Herrera, D., & Helmann, J. D. (2025). A ptsH mutation suppresses growth defects and antibiotic sensitivity in a cpgA mutant defective in metabolite proofreading. Journal of Bacteriology. https://doi.org/10.1128/jb.00162-25

Vancouver

Sachla AJ, Gaballa A, Herrera D, Helmann JD. A ptsH mutation suppresses growth defects and antibiotic sensitivity in a cpgA mutant defective in metabolite proofreading. Journal of Bacteriology. 2025. doi:10.1128/jb.00162-25

BibTeX
@article{Sachla2025,
  author = {Sachla, Ankita J and Gaballa, Ahmed and Herrera, Diana and Helmann, John D},
  title = {A ptsH mutation suppresses growth defects and antibiotic sensitivity in a cpgA mutant defective in metabolite proofreading},
  journal = {Journal of Bacteriology},
  year = {2025},
  doi = {10.1128/jb.00162-25}
}
Kostenlos starten →